advertisement
11.3.3 Apraclonidine, brimonidine (5)
Showing records 1 to 5
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine10574 The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter
Brown SM; Khanani AM; McCartney DL
American Journal of Ophthalmology 2004; 138: 149-51
10644 A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe
Garcia-Sanchez J; Rouland JF; Spiegel D; Pajic B; Cunliffe I; Traverso C; Landry J
British Journal of Ophthalmology 2004; 88: 877-83
10699 The effect of α2-agonist on IOP rise following Nd-YAG laser iridotomy
Kawai K; Sugiyama K; Kitazawa Y
Tokai Journal of Experimental and Clinical Medicine 2004; 29: 23-26
10841 Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension
Sharpe ED; Day DG; Beischel CJ; Rhodes JS; Stewart JA; Stewart WC
British Journal of Ophthalmology 2004; 88: 953-6
10579 Efficiency of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers
Carrasco Font C; Arias Puente A; Garcia Saenz MC; Villarejo Diaz Maroto I
Archivos de la Sociedad Española de Oftalmologia 2004; 79: 163-8
